Xembify

Xembify is a human normal immunoglobulin solution for subcutaneous use, prescribed for immune deficiencies. This sterile, ready-to-use therapy supports antibody levels in patients with primary immunodeficiencies. Suitable for home administration under medical guidance.

Human normal immunoglobulin like Xembify is used to treat primary immunodeficiencies in adults and children. It provides antibodies that the body cannot produce naturally, helping prevent infections. This therapy is also used for certain autoimmune conditions where the immune system attacks healthy tissues. Patients with weakened immune systems may benefit from regular immunoglobulin therapy.

Xembify works by supplementing the body’s natural antibody supply, which may help reduce the frequency and severity of infections. Users often report improved overall health and fewer sick days after consistent use. Some patients experience mild injection-site reactions, such as redness or swelling. The effects vary depending on individual immune needs and treatment consistency.

Store Xembify refrigerated between 2°C and 8°C; do not freeze. Keep the product in its original packaging to protect it from light. Always check the solution for particles or discoloration before use. Follow your healthcare provider’s instructions for proper handling and disposal of supplies. Avoid shaking the vial to prevent foaming.

Immunoglobulin therapy may interact with live vaccines, potentially reducing their effectiveness. Allow a gap of at least 3 months between immunoglobulin treatment and live vaccine administration. Discuss all current medications with your doctor before starting Xembify. Blood products and certain other therapies may interact; consult healthcare professionals for personalized advice.